Astrana Health Operating Margin vs. Return On Equity
ASTH Stock | 33.48 0.01 0.03% |
Astrana Health Operating Profit Margin |
|
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.2 | 0.155 |
|
|
For Astrana Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Astrana Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Astrana Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Astrana Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Astrana Health over time as well as its relative position and ranking within its peers.
Astrana |
Astrana Health's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Astrana Health Return On Equity vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Astrana Health's current stock value. Our valuation model uses many indicators to compare Astrana Health value to that of its competitors to determine the firm's financial worth. Astrana Health is number one stock in operating margin category among its peers. It also is number one stock in return on equity category among its peers reporting about 1.73 of Return On Equity per Operating Margin. As of now, Astrana Health's Operating Profit Margin is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Astrana Health's earnings, one of the primary drivers of an investment's value.Astrana Return On Equity vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Astrana Health |
| = | 0.06 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Astrana Health |
| = | 0.1 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Astrana Return On Equity Comparison
Astrana Health is currently under evaluation in return on equity category among its peers.
Astrana Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Astrana Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Astrana Health will eventually generate negative long term returns. The profitability progress is the general direction of Astrana Health's change in net profit over the period of time. It can combine multiple indicators of Astrana Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Accumulated Other Comprehensive Income | -14.4 M | -13.7 M | |
Operating Income | 84.6 M | 88.8 M | |
Income Before Tax | 89.8 M | 94.3 M | |
Net Income | 57.8 M | 60.7 M | |
Total Other Income Expense Net | 5.2 M | 5.5 M | |
Income Tax Expense | 32 M | 33.6 M | |
Net Income From Continuing Ops | 57.8 M | 31.4 M | |
Non Operating Income Net Other | -11.2 M | -10.6 M | |
Net Income Applicable To Common Shares | 56.4 M | 59.2 M | |
Interest Income | 14.2 M | 14.9 M | |
Net Interest Income | -1.9 M | -2 M | |
Change To Netincome | -3.3 M | -3.5 M | |
Net Income Per Share | 1.30 | 1.36 | |
Income Quality | 1.18 | 1.06 | |
Net Income Per E B T | 0.68 | 0.71 |
Astrana Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Astrana Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Astrana Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Astrana Health's important profitability drivers and their relationship over time.
Use Astrana Health in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Astrana Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astrana Health will appreciate offsetting losses from the drop in the long position's value.Astrana Health Pair Trading
Astrana Health Pair Trading Analysis
The ability to find closely correlated positions to Astrana Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Astrana Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Astrana Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Astrana Health to buy it.
The correlation of Astrana Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Astrana Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Astrana Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Astrana Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Astrana Health position
In addition to having Astrana Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Robots And Drones Thematic Idea Now
Robots And Drones
Large technology companies that are involved in development and manufacturing of drones, robots, or robotic equipment across mechanical engineering, electrical engineering, mathematics and computer science fields. Drones and robotics are projected to significantly grow in demand in the next 5 years. The Robots And Drones theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Robots And Drones Theme or any other thematic opportunities.
View All Next | Launch |
Check out Trending Equities. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
To fully project Astrana Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Astrana Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Astrana Health's income statement, its balance sheet, and the statement of cash flows.